The fork protection complex promotes parental histone recycling and epigenetic memory

Sebastian Jespersen Charlton, Valentin Flury, Yutaka Kanoh, Aitana Victoria Genzor, Leonie Kollenstart, Wantong Ao, Peter Brøgger, Melanie Bianca Weisser, Marek Adamus, Nicolas Alcaraz, Charlotte M. Delvaux de Fenffe, Francesca Mattiroli, Guillermo Montoya, Hisao Masai, Anja Groth*, Geneviève Thon*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

19 Citations (Scopus)
25 Downloads (Pure)

Abstract

The inheritance of parental histones across the replication fork is thought to mediate epigenetic memory. Here, we reveal that fission yeast Mrc1 (CLASPIN in humans) binds H3-H4 tetramers and operates as a central coordinator of symmetric parental histone inheritance. Mrc1 mutants in a key connector domain disrupted segregation of parental histones to the lagging strand comparable to Mcm2 histone-binding mutants. Both mutants showed clonal and asymmetric loss of H3K9me-mediated gene silencing. AlphaFold predicted co-chaperoning of H3-H4 tetramers by Mrc1 and Mcm2, with the Mrc1 connector domain bridging histone and Mcm2 binding. Biochemical and functional analysis validated this model and revealed a duality in Mrc1 function: disabling histone binding in the connector domain disrupted lagging-strand recycling while another histone-binding mutation impaired leading strand recycling. We propose that Mrc1 toggles histones between the lagging and leading strand recycling pathways, in part by intra-replisome co-chaperoning, to ensure epigenetic transmission to both daughter cells.

Original languageEnglish
JournalCell
Volume187
Issue number18
Pages (from-to)5029-5047
Number of pages41
ISSN0092-8674
DOIs
Publication statusPublished - 2024

Bibliographical note

Funding Information:
We thank Paul Russell for strains, Naoki Horikoshi and Hitoshi Kurumizaka for human histone H3.1-H4 tetramer, Katsunori Tanaka for sharing unpublished data, Danesh Moazed for sharing information prior to publication, Jose Rafael Ciges Tomas for advice, members of our labs for discussions, and the CPR/reNEW Genomics platform and the CPR Protein Production and Characterization Platform for support. G.T. was supported by the Novo Nordisk Foundation (NNF19OC0058686) and Carlsberg Foundation (CF15-0853, CF19-0200, and CF22-1467). A.G. was supported by the Novo Nordisk Foundation (NNF21OC0067425) and Lundbeck Foundation (R313-2019-448). H.M. was supported by Grant-in-Aid for Scientific Research (A) (JSPS 20H00463) and by Research Support Project for Life Science and Drug Discovery from AMED (JP23ama121009). G.M. was supported by the Novo Nordisk Foundation (NNF0024386, NNF17SA0030214, and NNF18OC0055061) and ERC (ERC_AdG_101096548 INTETOOLS). G.M. is a member of the Integrative Structural Biology Cluster (ISBUC) at the University of Copenhagen. Research at CPR is supported by the Novo Nordisk Foundation (grant NNF14CC0001). S.J.C. was supported by the Danish Cancer Society (R318-A18520). F.M. is funded by an ERC StG (851564). S.J.C. V.F. A.V.G. L.K. H.M. A.G. and G.T. designed the experiments; S.J.C. V.F. A.V.G. L.K. W.A. Y.K. and P.B. conducted the experiments; M.B.W. M.A. and G.M. conducted AlphaFold predictions and contributed corresponding sections to the paper; N.A. performed bioinformatics analysis; C.M.D.d.F. and F.M. produced histones and advised on biochemistry; and S.J.C. V.F. A.G. and G.T. wrote the paper. A.G. is co-founder and chief scientific officer (CSO) of Ankrin Therapeutics. A.G. is a member of the scientific advisory board of Molecular Cell. G.M. is a stockholder of Ensoma and a member of its scientific advisory board. The other authors declare no competing interests.

Funding Information:
We thank Paul Russell for strains, Naoki Horikoshi and Hitoshi Kurumizaka for human histone H3.1-H4 tetramer, Katsunori Tanaka for sharing unpublished data, Danesh Moazed for sharing information prior to publication, Jose Rafael Ciges Tomas for advice, members of our labs for discussions, and the CPR/reNEW Genomics platform and the CPR Protein Production and Characterization Platform for support. G.T. was supported by the Novo Nordisk Foundation ( NNF19OC0058686 ) and Carlsberg Foundation ( CF15-0853 , CF19-0200 , and CF22-1467 ). A.G. was supported by the Novo Nordisk Foundation ( NNF21OC0067425 ) and Lundbeck Foundation ( R313-2019-448 ). H.M. was supported by Grant-in-Aid for Scientific Research (A) ( JSPS 20H00463 ) and by Research Support Project for Life Science and Drug Discovery from AMED ( JP23ama121009 ). G.M. was supported by the Novo Nordisk Foundation ( NNF0024386 , NNF17SA0030214 , and NNF18OC0055061 ) and ERC ( ERC_AdG_101096548 INTETOOLS ). G.M. is a member of the Integrative Structural Biology Cluster (ISBUC) at the University of Copenhagen . Research at CPR is supported by the Novo Nordisk Foundation (grant NNF14CC0001 ). S.J.C. was supported by the Danish Cancer Society ( R318-A18520 ). F.M. is funded by an ERC StG ( 851564 ).

Publisher Copyright:
© 2024 The Authors

Keywords

  • chromatin replication
  • Claspin
  • DNA replication
  • epigenetic inheritance
  • epigenome maintenance
  • fission yeast
  • H3K9 methylation
  • heterochromatin
  • histone chaperone
  • histone recycling
  • mouse embryonic stem cells

Cite this